Technical Analysis for EWTX - Edgewise Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 31.94 | -0.05% | -0.02 |
EWTX closed up 1.4 percent on Wednesday, November 20, 2024, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | -0.05% | |
| Lower Bollinger Band Walk | Weakness | -0.05% | |
| Oversold Stochastic | Weakness | -0.05% | |
| 50 DMA Support | Bullish | 1.35% | |
| Bullish Engulfing | Bullish | 1.35% | |
| Lower Bollinger Band Walk | Weakness | 1.35% | |
| Multiple of Ten Bullish | Other | 1.35% | |
| Lower Bollinger Band Touch | Weakness | 1.35% | |
| Oversold Stochastic | Weakness | 1.35% | |
| Hammer Candlestick | Bullish | 3.72% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 4 minutes ago |
| Up 2% | 4 minutes ago |
| Up 1% | 4 minutes ago |
| Possible NR7 | about 20 hours ago |
| 60 Minute Opening Range Breakout | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Muscular Dystrophy Small Molecule Therapies Muscle Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Muscular Dystrophy Small Molecule Therapies Muscle Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 38.12 |
| 52 Week Low | 5.93 |
| Average Volume | 1,269,665 |
| 200-Day Moving Average | 21.06 |
| 50-Day Moving Average | 30.37 |
| 20-Day Moving Average | 34.01 |
| 10-Day Moving Average | 33.42 |
| Average True Range | 1.77 |
| RSI (14) | 46.81 |
| ADX | 29.41 |
| +DI | 21.37 |
| -DI | 24.50 |
| Chandelier Exit (Long, 3 ATRs) | 32.81 |
| Chandelier Exit (Short, 3 ATRs) | 35.13 |
| Upper Bollinger Bands | 37.27 |
| Lower Bollinger Band | 30.75 |
| Percent B (%b) | 0.18 |
| BandWidth | 19.16 |
| MACD Line | 0.27 |
| MACD Signal Line | 1.05 |
| MACD Histogram | -0.779 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 33.47 | ||||
| Resistance 3 (R3) | 33.35 | 32.71 | 33.22 | ||
| Resistance 2 (R2) | 32.71 | 32.32 | 32.77 | 33.13 | |
| Resistance 1 (R1) | 32.33 | 32.08 | 32.52 | 32.46 | 33.05 |
| Pivot Point | 31.70 | 31.70 | 31.79 | 31.76 | 31.70 |
| Support 1 (S1) | 31.32 | 31.31 | 31.51 | 31.44 | 30.85 |
| Support 2 (S2) | 30.68 | 31.07 | 30.74 | 30.77 | |
| Support 3 (S3) | 30.30 | 30.68 | 30.68 | ||
| Support 4 (S4) | 30.43 |
